Skip to content
Opens in a new window
S2026 Ep8: Building the Pediatric Psoriasis Treatment Ladder
22 September 2026

S2026 Ep8: Building the Pediatric Psoriasis Treatment Ladder

Don't Be Rash®: The Official Podcast of the Society for Pediatric Dermatology

About

In part 2 of their conversation, Lisa Swanson, MD, and host Andrew C. Krakowski, MD, walk step by step through pediatric psoriasis treatment. Swanson starts most patients on generic topicals: clobetasol for the body, a topical calcineurin inhibitor for the face and folds, and fluocinolone oil for the scalp. She then moves quickly to nonsteroidal roflumilast cream and foam for families who want to avoid ongoing steroids, and shares a practical tip for getting medication out of the foam can. When topicals aren't enough, she reviews the biologics with pediatric approvals, including etanercept, ustekinumab, ixekizumab, secukinumab, and newer pediatric indications for guselkumab and risankizumab. She also covers icotrokinra, a new oral IL-23 receptor blocker for patients 12 and older, including how to take it and how to navigate early insurance denials. The episode closes with adherence tips for teens and how a prize box makes injection day easier.

Don't Be Rash is produced by Dermatology Times in collaboration with the Society for Pediatric Dermatology. Learn more at pedsderm.net. Have a topic you think we should cover? Email DTeditor@mmhgroup.com to join the conversation.